Xiaojing Shi
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Extracellular vesicles in disease
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
Papers in
-
- Ubiquitin and proteasome pathways 9
- Histone Deacetylase Inhibitors Research 6
- Epigenetics and DNA Methylation 5
- Protein Degradation and Inhibitors 4
- Cancer-related gene regulation 3
- Cell death mechanisms and regulation 3
-
- Click Chemistry and Applications 3
- Co-authors
- Hong‐Min Liu (11 shared papers)Hong‐Min Liu (14 shared papers)Yi‐Chao Zheng (8 shared papers)Bin Yu (12 shared papers)En Zhang (5 shared papers)Ping‐Ping Qi (5 shared papers)Yong‐Cheng Ma (4 shared papers)Ying‐Chao Duan (3 shared papers)
- Journals
- European Journal of Medicinal Chemistry (7 papers)Acta Pharmaceutica Sinica B (3 papers)Scientific Reports (3 papers)European Journal of Pharmacology (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Xiaojing Shi
49 papers receiving 2.1k citations
Xiaojing Shi's Hit Papers
Peers
Comparison fields: 5 of 102
- Cancer Research 303
- Molecular Biology 1.4k
- Neurology 160
- Organic Chemistry 538
- Toxicology 52
Countries citing papers authored by Xiaojing Shi
This map shows the geographic impact of Xiaojing Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Shi more than expected).
Fields of papers citing papers by Xiaojing Shi
This network shows the impact of papers produced by Xiaojing Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Shi. The network helps show where Xiaojing Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaojing Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury via exosomal miR-124 Hit paper breakdown → | 2019 | 379 |
| 2 | 2013 | 229 | |
| 3 | 2009 | 201 | |
| 4 | 2015 | 153 | |
| 5 | 2015 | 146 | |
| 6 | 2020 | 111 | |
| 7 | 2016 | 104 | |
| 8 | 2016 | 71 | |
| 9 | 2019 | 67 | |
| 10 | 2022 | 67 | |
| 11 | 2013 | 60 | |
| 12 | 2019 | 41 | |
| 13 | 2021 | 40 | |
| 14 | 2014 | 38 | |
| 15 | 2016 | 35 | |
| 16 | 2014 | 34 | |
| 17 | 2015 | 27 | |
| 18 | 2016 | 26 | |
| 19 | 2016 | 25 | |
| 20 | 2021 | 24 |
About Xiaojing Shi
Xiaojing Shi is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Surgery and Epidemiology, having authored 51 papers that have together received 2.2k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (9 papers), Histone Deacetylase Inhibitors Research (6 papers), Autophagy in Disease and Therapy (5 papers), Epigenetics and DNA Methylation (5 papers), Protein Degradation and Inhibitors (4 papers), Click Chemistry and Applications (3 papers), Cancer-related gene regulation (3 papers) and Cell death mechanisms and regulation (3 papers). The work is most often cited by research in Cancer Research (303 citations), Molecular Biology (1.4k citations), Neurology (160 citations), Organic Chemistry (538 citations) and Toxicology (52 citations). Xiaojing Shi has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Hong‐Min Liu, Hong‐Min Liu, Yi‐Chao Zheng, Bin Yu, En Zhang, Ping‐Ping Qi, Yong‐Cheng Ma, Ying‐Chao Duan, Xian-Wei Ye and Mengmeng Wang. Their work appears in journals such as European Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica B, Scientific Reports, European Journal of Pharmacology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.